Biotahealth Sociedad Limitada.

Biotasmart, based in Valencia, Spain, specializes in a microbiota platform for personalized clinical nutrition, using advanced technology to provide healthcare professionals with insights for tailored nutritional recommendations. Founded in 2024 by CEO Olga Carbonell, Biotasmart operates from Valencia, Spain, focusing on the analysis of gut microbiota for dietary optimization. In January 2026, Biotasmart raised EUR 500,000 in venture funding led by Angels Capital, with participation from Maicerías Españolas SA and Empresa Nacional de Innovacion. Biotasmart offers a data-driven microbiota platform designed for personalized clinical nutrition.

Their services include advanced gut microbiota analysis using next-generation sequencing technology, which accurately identifies bacterial composition in patients' guts. Detailed reports highlight how microbiota influences nutrient absorption and overall health, targeting professionals across nutrition clinics, anti-aging centers, and sports clubs primarily in Spain and Europe. Biotasmart generates revenue through microbiota analysis services, offering the Essential Test at EUR 249 and the Advanced Test at EUR 349. Revenue is derived from direct business-to-business relationships with healthcare providers who integrate these services into their offerings, ensuring that clients receive customized reports based on comprehensive laboratory analyses, delivered within 3-4 weeks.

In February 2026, Biotasmart raised EUR 500,000 in venture funding to enhance its presence in longevity clinics, integrative health centers, and sports clubs. The funding will also support team expansion to facilitate continued growth. The company plans to release new products aimed at broadening its offering to healthcare professionals and is looking to expand into new markets across Europe by 2027.